Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 30,000 | 2,687 | 126,162 | 15,360 | 59,417 |
| Gross Profit | 30,000 | 2,687 | 126,162 | 15,360 | 59,417 |
| Operating Expenses | 91,869 | 78,700 | 64,576 | 72,726 | 68,568 |
| Operating Income | -61,869 | -76,013 | 61,586 | -57,366 | -9,151 |
| Other Income | -1,717 | -2,472 | -2,249 | 2,577 | 2,554 |
| Pre-tax Income | -63,586 | -78,485 | 59,337 | -54,789 | -6,597 |
| Net Income Continuous | -63,586 | -78,485 | 59,337 | -54,789 | -6,597 |
| Net Income | $-63,586 | $-78,485 | $59,337 | $-54,789 | $-6,597 |
| EPS Basic Total Ops | -1.14 | -1.77 | 1.67 | -1.97 | -0.33 |
| EPS Basic Continuous Ops | -1.14 | -1.77 | 1.67 | -1.97 | -0.33 |
| EPS Diluted Total Ops | -1.14 | -1.77 | 1.57 | -1.97 | -0.33 |
| EPS Diluted Continuous Ops | -1.14 | -1.77 | 1.56 | -1.97 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -1.14 | -1.77 | 1.57 | -1.97 | -0.33 |
| EBITDA(a) | $-60,358 | $-73,637 | $63,209 | $-56,345 | $-8,181 |